JAK2 and Chronic Eosinophilic Leukemia, Not Otherwise Specified: More importantly, we found that cellular growth in IR cells was obviously repressed by JAK2 inhibition or knock-down (Figure 4D, E), indicating that a JAK2 inhibitor, to a certain extent, may represent an effective alternative therapy in Imatinib-resistant CEL.